Skip to main content
Scilex Holding Co logo

Scilex Holding Co — Investor Relations & Filings

Ticker · SCLX ISIN · US80880W2052 LEI · 529900SPEA2C7YTTYP45 US Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2023-03-21 Capital/Financing Update
Country US United States of America
Listing US SCLX

About Scilex Holding Co

https://www.scilexholding.com/

Scilex Holding Co. is a company focused on the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company's portfolio targets indications with high unmet medical needs and features therapies with proprietary drug delivery systems. These systems include an advanced topical patch technology for optimized drug delivery through the skin, an anti-inflammatory oral solution designed for individualized dosing in high-risk patients, and a liquid ready-to-use analgesic for migraine relief. Scilex aims to provide effective alternatives to opioid medications to improve patient quality of life.

Recent filings

Filing Released Lang Actions
8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content details the entry into a material definitive agreement involving convertible debentures and a securities purchase agreement, including terms of the financing and related agreements. It also references a press release and exhibits related to the financing transaction. There are no financial statements or comprehensive financial data typical of annual or interim reports. The document is primarily an announcement of a financing event and related agreements, which fits the category of Capital/Financing Update (CAP). The length and detail confirm it is not a brief announcement or a simple press release but a formal filing describing financing activities.
2023-03-21 English
FORM 4 SUBMISSION
Director's Dealing
2023-03-20 English
424B3
Capital/Financing Update Classification · 95% confidence The document is a detailed prospectus filed pursuant to Rule 424(b)(3) related to the resale of common stock by a selling securityholder. It includes extensive information about the company, risk factors, business combination, management discussion and analysis, legal matters, and financial statements. The document is not an earnings release, annual report, or management report but rather a registration prospectus for equity financing. This fits the definition of a Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes through a registered resale offering. The document length and content confirm it is the actual prospectus, not just an announcement or certification.
2023-03-20 English
Regulatory Filings 2023
Regulatory Filings
2023-03-20 English
Regulatory Filings 2023
Regulatory Filings
2023-03-20 English
424B3
Capital/Financing Update Classification · 95% confidence The document is a detailed prospectus filed pursuant to Rule 424(b)(3) related to the issuance and resale of shares and warrants of Scilex Holding Company. It includes extensive information about the securities offered, the business combination, risk factors, management discussion and analysis, business overview, and other detailed disclosures typical of a registration statement or prospectus. The document is not an annual report, earnings release, or any other financial report but rather a capital markets document related to securities issuance and resale. This fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes through the offering and resale of shares and warrants.
2023-03-17 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.